Ploughshare Innovations, the technology transfer office for the Defence Science and Technology Laboratory (Dstl) based at Porton Science Park near Salisbury, has funded the development of a revolutionary test that can predict whether coronavirus patients will develop sepsis before symptoms appear.
A sum of £200,000 of initial seed funding has been awarded to Presymptom Health to accelerate the development of the test which will transform clinicians’ ability to provide appropriate treatment, potentially saving lives.
Hetti Barkworth-Nanton, Ploughshare’s CEO, in committing to the funding said:
- “It is unusual for Ploughshare to make investments such as this, however, given how much potential this technology has we saw the value in accelerating its development. Beyond COVID-19, the test will have the potential to help with the treatment of the 49m people worldwide affected by sepsis every year, and to also prepare us for future pandemics.”
-(2).png?sfvrsn=3b7e3050_0){kind=logo}
